incivo
janssen-cilag (new zealand) ltd - telaprevir 375mg; - film coated tablet - 375 mg - active: telaprevir 375mg excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium hypromellose acetate succinate iron oxide yellow macrogol 3350 microcrystalline cellulose polyvinyl alcohol purified talc sodium laurilsulfate sodium stearyl fumarate titanium dioxide - incivo, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype 1 chronic hepatitis c in adult patients with compensated liver disease (including cirrhosis): - who are treatment naive - who have previously been treated with interferon alfa (pegylated or nonpegylated) alone or in combination with ribavirin, including relapsers, partial responders and null responders.
incivo
janssen-cilag international n.v. - telaprevir - hepatitis c, chronic - antivirals for systemic use - incivo, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype-1 chronic hepatitis c in adult patients with compensated liver disease (including cirrhosis):who are treatment naïve;who have previously been treated with interferon alfa (pegylated or non-pegylated) alone or in combination with ribavirin, including relapsers, partial responders and null responders.
incivek tablet
vertex pharmaceuticals (canada) incorporated - telaprevir - tablet - 375mg - telaprevir 375mg - hcv antivirals
incivo
janssen-cilag pty ltd - telaprevir -
incivo 375mg tablets
janssen-cilag ltd - telaprevir - tablet - 375mg
incivo 375mg film coated tablet film-coated tablet
janssen-cilag - telaprevir - film-coated tablet - 375 mg
stocrin 600 mg tablets
merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - film coated tablets - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .
viramune tablets
boehringer ingelheim israel ltd. - nevirapine - tablets - nevirapine 200 mg - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.
daklinza
bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - hepatitis c, chronic - antivirals for systemic use - daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults (see sections 4.2, 4.4 and 5.1). for hcv genotype specific activity, see sections 4.4 and 5.1.,
prograf ampoules
astellas pharma international b.v., israel - tacrolimus - concentrate for solution for infusion - tacrolimus 5 mg/ml - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.